Analyst consensus rating
CAMP4 Therapeutics Analyst Rating: Strong Buy
CAMP is rated Strong Buy by 6 analysts with a $9.92 target. As of 2026-08-26.
Direct answer
CAMP4 Therapeutics's consensus rating is Strong Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $9.92.
Forecast evidence checked August 26, 2026.
Get free CAMP4 Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.45
- Average price target
- $9.92
- High price target
- $15.00
- Low price target
- $6.50
- Low target gap
- +46.1%
- Target upside
- +122.8%
- High target gap
- +237.1%
- Target range width
- 191%
- Consensus rating
- Strong Buy
- Analysts
- 6
- Evidence date
- August 26, 2026
- Valid through
- September 2, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for CAMP4 Therapeutics?
CAMP4 Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $9.92.
How far are CAMP4 Therapeutics's low and high targets from the recorded price?
The low target implies +46.1%, while the high target implies +237.1%.
How many analysts are included in CAMP4 Therapeutics's consensus?
The verified consensus includes 6 analysts.
How is CAMP4 Therapeutics's target upside or downside calculated?
The average target of $9.92 is divided by the recorded price of $4.45, then one is subtracted to produce +122.8%. This does not guarantee a future return.
When was CAMP4 Therapeutics's analyst forecast verified?
The data was verified on 2026-08-26. The dataset is valid through 2026-09-02.